International Conference CHRONIC MYELOID LEUKEMIA: Biology and Therapy

Inspired by the success of the 13th ESH-iCMLf events that took place in Estoril (Portugal) last year, the 2012 program will once again include a strong clinical component.

The poster walks and small scientific workshops for non-clinical scientists that were so successful in 2011 will also be featured in Baltimore 2012. There will also be opportunities to organize corporate symposia in conjunction with the meeting 2012.

Speakers at this meeting will present the newest and often unpublished data that relate to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) Aspects of treatment including prediction and definition of responses, drugs used in combination, molecular monitoring, targeting residual stem cells and approaches to cure.

+ show speakers and program
not specified

20 Sep - 23 Sep 2012

United States of America
meeting website